Peripheral GABAA receptors - Physiological relevance and therapeutic implications

IF 12 1区 医学 Q1 PHARMACOLOGY & PHARMACY
Milica Gajić Bojić , Jovana Aranđelović , Ranko Škrbić , Miroslav M. Savić
{"title":"Peripheral GABAA receptors - Physiological relevance and therapeutic implications","authors":"Milica Gajić Bojić ,&nbsp;Jovana Aranđelović ,&nbsp;Ranko Škrbić ,&nbsp;Miroslav M. Savić","doi":"10.1016/j.pharmthera.2024.108759","DOIUrl":null,"url":null,"abstract":"<div><div>The role of γ- aminobutyric acid (GABA) and GABA<sub>A</sub> receptors is not only essential for neurotransmission in the central nervous system (CNS), but they are also involved in communication in various peripheral tissues such as the pancreas, liver, kidney, gastrointestinal tract, trachea, immune cells and blood vessels. GABA<sub>A</sub> receptors located outside the CNS (“peripheral GABA<sub>A</sub> receptors”) enable both neuronal and non-neuronal GABA-ergic signaling in various physiological processes and are generally thought to have similar properties to the extrasynaptic receptors in the CNS. By activating these peripheral receptors, GABA and various GABA<sub>A</sub> receptor modulators, including drugs such as benzodiazepines and general anesthetics, may contribute to or otherwise affect the maintenance of general body homeostasis. However, the existing data in the literature on the role of non-neuronal GABA-ergic signaling in insulin secretion, glucose metabolism, renal function, intestinal motility, airway tone, immune response and blood pressure regulation are far from complete. In fact, they mainly focus on the identification of components for the local synthesis and utilization of GABA and on the expression repertoire of GABA<sub>A</sub> receptor subunits rather than on subunit composition, activation effects and (sub)cellular localization. A deeper understanding of how modulation of peripheral GABA<sub>A</sub> receptors can have significant therapeutic effects on a range of pathological conditions such as multiple sclerosis, diabetes, irritable bowel syndrome, asthma or hypertension could contribute to the development of more specific pharmacological strategies that would provide an alternative or complement to existing therapies. Selective GABA<sub>A</sub> receptor modulators with improved peripheral efficacy and reduced central side effects would therefore be highly desirable first-in-class drug candidates. This review updates recent advances unraveling the molecular components and cellular determinants of the GABA signaling machinery in peripheral organs, tissues and cells of both, humans and experimental animals.</div></div>","PeriodicalId":402,"journal":{"name":"Pharmacology & Therapeutics","volume":"266 ","pages":"Article 108759"},"PeriodicalIF":12.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0163725824001797","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The role of γ- aminobutyric acid (GABA) and GABAA receptors is not only essential for neurotransmission in the central nervous system (CNS), but they are also involved in communication in various peripheral tissues such as the pancreas, liver, kidney, gastrointestinal tract, trachea, immune cells and blood vessels. GABAA receptors located outside the CNS (“peripheral GABAA receptors”) enable both neuronal and non-neuronal GABA-ergic signaling in various physiological processes and are generally thought to have similar properties to the extrasynaptic receptors in the CNS. By activating these peripheral receptors, GABA and various GABAA receptor modulators, including drugs such as benzodiazepines and general anesthetics, may contribute to or otherwise affect the maintenance of general body homeostasis. However, the existing data in the literature on the role of non-neuronal GABA-ergic signaling in insulin secretion, glucose metabolism, renal function, intestinal motility, airway tone, immune response and blood pressure regulation are far from complete. In fact, they mainly focus on the identification of components for the local synthesis and utilization of GABA and on the expression repertoire of GABAA receptor subunits rather than on subunit composition, activation effects and (sub)cellular localization. A deeper understanding of how modulation of peripheral GABAA receptors can have significant therapeutic effects on a range of pathological conditions such as multiple sclerosis, diabetes, irritable bowel syndrome, asthma or hypertension could contribute to the development of more specific pharmacological strategies that would provide an alternative or complement to existing therapies. Selective GABAA receptor modulators with improved peripheral efficacy and reduced central side effects would therefore be highly desirable first-in-class drug candidates. This review updates recent advances unraveling the molecular components and cellular determinants of the GABA signaling machinery in peripheral organs, tissues and cells of both, humans and experimental animals.
外周GABAA受体-生理相关性和治疗意义。
γ-氨基丁酸(GABA)和GABAA受体的作用不仅是中枢神经系统(CNS)的神经传递所必需的,而且还参与各种外周组织如胰腺、肝脏、肾脏、胃肠道、气管、免疫细胞和血管的通讯。位于中枢神经系统外的GABAA受体(“外周GABAA受体”)在各种生理过程中使神经元和非神经元gaba能信号传导,通常被认为与中枢神经系统内的突触外受体具有相似的特性。通过激活这些外周受体,GABA和各种GABAA受体调节剂,包括苯二氮卓类药物和全身麻醉剂,可能有助于或以其他方式影响全身稳态的维持。然而,关于非神经元gaba能信号在胰岛素分泌、葡萄糖代谢、肾功能、肠蠕动、气道张力、免疫反应、血压调节等方面的作用,现有文献资料还很不完整。事实上,他们主要关注GABA的局部合成和利用组分的鉴定以及GABAA受体亚基的表达库,而不是亚基的组成、激活作用和(亚)细胞定位。更深入地了解外周GABAA受体的调节如何对一系列病理状况(如多发性硬化症、糖尿病、肠易激综合征、哮喘或高血压)产生显著的治疗作用,可能有助于开发更具体的药理学策略,为现有疗法提供替代或补充。因此,具有改善外周疗效和减少中枢副作用的选择性GABAA受体调节剂将是非常理想的一流候选药物。本文综述了人类和实验动物外周器官、组织和细胞中GABA信号机制的分子组成和细胞决定因素的最新进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
23.00
自引率
0.70%
发文量
222
审稿时长
90 days
期刊介绍: Pharmacology & Therapeutics, in its 20th year, delivers lucid, critical, and authoritative reviews on current pharmacological topics.Articles, commissioned by the editor, follow specific author instructions.This journal maintains its scientific excellence and ranks among the top 10 most cited journals in pharmacology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信